Evaluation of a New Potential Bevacizumab Biosimilar in Corneal Neovascularization

Objectives: To compare the antiangiogenic effects of bevacizumab and a new potential bevacizumab biosimilar (anti-human VEGF GU01) on suture-induced corneal neovascularization (CNV) in rabbits. Materials and Methods: CNV was induced in the right eyes of 15 rabbits by placing 7-0 black silk suture i...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Armağan Özgür, Nilüfer Yeşilırmak, Mehmet Arda İnan, Emin Ümit Bağrıaçık, Mehmet Cüneyt Özmen
Format:	Artigo
Jezik:	Inglês
Izdano:	Turkish Ophthalmology Society 2025-12-01
Serija:	Türk Oftalmoloji Dergisi
Teme:	bevacizumab bevacizumab biosimilar anti-human vegf gu01 corneal neovascularization
Online dostop:	https://www.oftalmoloji.org/articles/evaluation-of-a-new-potential-bevacizumab-biosimilar-in-corneal-neovascularization/doi/tjo.galenos.2025.34783
Oznake:	Označite Brez oznak, prvi označite!